Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanchorBio Presents Two Late-Breaking Abstracts at the Society for Immunotherapy of Cancer 2025 Demonstrating Best-in-Class Potential of HCB101 in Advanced Cancers 2025-11-07 22:00
Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine 2025-11-07 21:30
Alebund Presents Phase 3 Trial Results of AP301 at the American Society of Nephrology (ASN) 2025 Congress 2025-11-07 20:00
Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI-Enabled Drug Development 2025-11-07 14:00
Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025 2025-11-07 09:00
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut 2025-11-07 08:10
UPL launches a global campaign '#AFarmerCan' ahead of COP30, championing farmers in climate action 2025-11-07 01:53
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study 2025-11-06 21:30
Leading Fertility Specialist Associate Professor Gavin Sacks joins Genea 2025-11-06 16:09
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy 2025-11-06 14:11
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia 2025-11-06 08:00
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025 2025-11-05 21:00
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies 2025-11-05 20:07
HanchorBio Presents Preclinical Data on HCB301 at SITC 2025 2025-11-05 20:00
SingHealth Duke-NUS Launches Two New Global Health Centres to Advance Allied Health and Pharmacy Practices in Asia 2025-11-05 15:43
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral Tablet, Phase Ib Study of ASC30 Injection, and Preclinical Study of Combination of ASC31 and ASC47 at ObesityWeek® 2025 2025-11-05 08:10
Angel Yeast starts Operating New 11,000-Ton Yeast Protein Production Line to Meet Global Demand for Sustainable Nutrition 2025-11-05 07:52
Grit Biotherapeutics Invited to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801 2025-11-04 21:15
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction 2025-11-04 20:04
Hasten Sets a New Benchmark for Global Expansion‌ by Building an End-to-End Asia-Pacific Healthcare Commercial Platform 2025-11-04 11:15
1 4 5 6 7 8 523